Health

AMR Action Fund added $20m to a round for the drug-resistant bacteria treatment developer following a Mayo Clinic-backed first close last May.

The China Resources and Legend Holdings-backed vaccine technology developer floated in Hong Kong in a $97.7m offering following nearly $460m in funding.

Sector report: oncology

Oncology Q1 2022 editorial by James Mawson, editor in chief, Global Corporate Venturing

PTT Oil and Retail, Central Pattana, The Vacharaphol, TKS Technologies, Ramkhamaeng Hospital, Modernform, MC Group, Singha and Benchachinda are among the fund's limited partners.

Sector report: healthcare

Several corporates backed the blockchain technology developer in its latest round, boosting its valuation to $1bn. Valuations of blockchain tech companies have soared along with the interest in speculative assets classes inherently linked to the blockchain in recent times.

Smiths Medical and WuXi AppTec are exiting infusion pump developer Ivenix in an acquisition that could reach $240m, while AI software developer Syntiant raised $55m from investors including Renesas.

The Global University Venturing deal net rounds up the smaller investments from across the university innovation ecosystem.

Several corporates helped hydrogen refuelling service H2 Mobility Deutschland collect $122m while enterprise optimisation software developer Skan.ai closed a $40m Dell-led series B round

GV, Optum, Children’s Medical Center Corporation and Blue Cross Blue Shield of Massachusetts returned to take the behavioural health provider’s overall funding past $200m.